abstract |
The present invention is directed to novel retinoid-related orphan receptor gamma (RORĪ³) modulators, processes for their preparation, pharmaceutical compositions containing these modulators, and their use in the treatment of inflammatory, metabolic and autoimmune diseases mediated by RORĪ³. |